See with certainty Optain is an international MedTech company, developing advanced AI software solutions. Eyetelligence Assure software analyses full-colour fundus images to screen for referable eye diseases including glaucoma, diabetic retinopathy, and age-related macular degeneration. Additionally, the technology can screen for cardiovascular diseases and provide a risk assessment profile. Our vision is to harness the power of AI to provide affordable clinical support tools that make disease screening easy, anytime, anywhere.
Location: United States, New York, New City
Employees: 1-10
Total raised: $38M
Funding Rounds 2
| Date | Series | Amount | Investors |
| 11.09.2025 | Series A | $26M | Insight Pa... |
| 09.05.2023 | Seed | $12M | - |
Mentions in press and media 10
| Date | Title | Description |
| 10.11.2025 | Optain Health Acquires EyePACS | Optain Health, an Akron, OH-based healthcare technology company applying artificial intelligence (AI), robotic retinal imaging, and teleophthalmology, acquired EyePACS, a Santa Cruz, CA-based provider of a teleophthalmology network. The amo... |
| 11.09.2025 | Optain Health Secures $26M Series A for Global AI-Powered Retinal Screening Expansion | Optain Health secures $26 million in Series A funding. Insight Partners leads the round. Seven major U.S. health systems invest. This capital fuels global expansion of Optain's AI-powered robotic retinal imaging platform. It brings advanced... |
| 11.09.2025 | Optain Health: $26 Million Secured To Expand AI-Based Retinal Screening | Optain Health, a healthcare technology company focused on early disease detection through retinal imaging and artificial intelligence, has closed a $26 million Series A funding round. The investment was led by Insight Partners and joined by... |
| 10.09.2025 | Optain Health Closes $26 Million Series A to Bring Oculomics to Primary Care and Beyond | Insight Partners leads; seven major U.S. health systems join. Funding accelerates the global rollout of Optain's advanced robotic retinal imaging, AI, and teleophthalmology platform. NEW YORK, Sept. 10, 2025 /PRNewswire/ -- Optain Health, a... |
| 10.09.2025 | Optain Health Raises $26M in Series A Funding | Optain Health, a Akron, OH-based healthcare technology company applying artificial intelligence (AI), robotic retinal imaging, and teleophthalmology to detect eye and systemic disease earlier, raised $26M in Series A funding. The round was ... |
| 10.09.2025 | Optain Health Secures $26M for AI-Powered Retinal Screening | What You Should Know: – Optain Health, a healthcare technology company specializing in AI, robotic retinal imaging, and teleophthalmology secures $26M in Series A funding round led by Insight Partners with participation from existing invest... |
| 09.05.2023 | Optain Launches with $12M in Seed Funding | Optain, a New York-based AI company that uses photos of the eye to detect and prevent early stage disease, raised $12M in Seed funding. Ascertain, a collaboration between Aegis Ventures and Northwell Holdings to develop healthcare AI compan... |
| 09.05.2023 | Using AI for eye disease detection, Optain launches with $12M seed | Optain is the first company to come out of Ascertain from Northwell Health and Aegis Ventures In April 2022, Northwell Health, New York’s largest healthcare provider, and Aegis Ventures, a New York-based startup studio, came together to cre... |
| - | Optain | “Discover AI retinal imaging for early detection of chronic diseases. Enhance diagnosis speed, reduce missed cases, and improve patient outcomes. Learn more today.” |
| - | Optain | “Optain” |